31![Mississippi Division Of Medicaid Preferred Drug List Changes P&T Meeting Date: May 13, 2014 PDL Changes Effective Date: July 1, 2014 The following changes will be made to the Preferred Drug List (PDL), effective July 1, Mississippi Division Of Medicaid Preferred Drug List Changes P&T Meeting Date: May 13, 2014 PDL Changes Effective Date: July 1, 2014 The following changes will be made to the Preferred Drug List (PDL), effective July 1,](https://www.pdfsearch.io/img/4b3c3398accce344c24a1f47ad39d985.jpg) | Add to Reading ListSource URL: www.medicaid.ms.govLanguage: English - Date: 2014-06-16 17:05:55
|
---|
32![Adjuvant Systemic Therapy Version 1 Adjuvant Systemic Therapy for Early Stage (Lymph Node Negative and Lymph Node Positive) Breast Cancer Adjuvant Systemic Therapy Version 1 Adjuvant Systemic Therapy for Early Stage (Lymph Node Negative and Lymph Node Positive) Breast Cancer](https://www.pdfsearch.io/img/e3ad6c1f3b1b1d06080c7d011ff68d70.jpg) | Add to Reading ListSource URL: www.albertahealthservices.caLanguage: English - Date: 2014-05-09 12:35:19
|
---|
33![HIGHLIGHTS OF PRESCRIBING INFORMATION These hig hlights do not include all the informatio n nee ded to use AROM ASIN safely and effectively. See full prescribing infor mation for AROM ASIN. AROM ASIN® (e xe mestane) tab HIGHLIGHTS OF PRESCRIBING INFORMATION These hig hlights do not include all the informatio n nee ded to use AROM ASIN safely and effectively. See full prescribing infor mation for AROM ASIN. AROM ASIN® (e xe mestane) tab](https://www.pdfsearch.io/img/95ca5aa0c3f915f4b65ac5cf18bdeef9.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2014-05-06 13:28:06
|
---|
34![](https://www.pdfsearch.io/img/03b4152ed41386d47d779cec1664c6f3.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
35![Syndax Pharmaceuticals Inc. to Present Entinostat Data Showing Benefit in Combination in Advanced Breast Cancer at ASCO WALTHAM, Mass., May 24 /PRNewswire/ -- Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics co Syndax Pharmaceuticals Inc. to Present Entinostat Data Showing Benefit in Combination in Advanced Breast Cancer at ASCO WALTHAM, Mass., May 24 /PRNewswire/ -- Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics co](https://www.pdfsearch.io/img/731dec5d65b252d462293834b2e0b19e.jpg) | Add to Reading ListSource URL: www.forwardventures.comLanguage: English - Date: 2011-08-15 11:58:27
|
---|
36![Syndax Pharmaceutical’s Positive Phase 2 Data Supports Potential for Entinostat in Advanced Breast Cancer -- Entinostat in combination with exemestane prolonged progression-free survival --- Randomized, placebo-control Syndax Pharmaceutical’s Positive Phase 2 Data Supports Potential for Entinostat in Advanced Breast Cancer -- Entinostat in combination with exemestane prolonged progression-free survival --- Randomized, placebo-control](https://www.pdfsearch.io/img/c591dc6be22e1aea385445adf3a2daff.jpg) | Add to Reading ListSource URL: www.forwardventures.comLanguage: English - Date: 2011-09-09 08:47:22
|
---|
37![Allos Therapeutics Initiates Phase 2 Study of PDX in Patients with Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder Allos Therapeutics Initiates Phase 2 Study of PDX in Patients with Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder](https://www.pdfsearch.io/img/afbcee3c49970b67a1d81f703abcb5df.jpg) | Add to Reading ListSource URL: www.forwardventures.comLanguage: English - Date: 2011-08-15 11:58:27
|
---|
38![Page 1 of 4 – Exemestane Tablets IN CASE OF EMERGENCY Emergency Phone: ([removed]Material Safety Data Sheet Page 1 of 4 – Exemestane Tablets IN CASE OF EMERGENCY Emergency Phone: ([removed]Material Safety Data Sheet](https://www.pdfsearch.io/img/74b7d7daf960bcbbd0d5182c3ee5485f.jpg) | Add to Reading ListSource URL: bi-msds.e3solutionsinc.comLanguage: English - Date: 2014-04-09 14:06:57
|
---|
39![San Antonio Breast Cancer – Cancer Therapy and Research Center at UT Health Science Center – December 10-14, 2013 Breast Cancer Prevention using Anastrozole in Postmenopausal Women at High Risk: First results of the San Antonio Breast Cancer – Cancer Therapy and Research Center at UT Health Science Center – December 10-14, 2013 Breast Cancer Prevention using Anastrozole in Postmenopausal Women at High Risk: First results of the](https://www.pdfsearch.io/img/8fa7d50d1a3cd9bb4590c7e523d23b21.jpg) | Add to Reading ListSource URL: www.germanbreastgroup.deLanguage: English - Date: 2013-12-16 07:43:16
|
---|
40![HSI_MembersAlert_SEPT08:HSI_MembersAlert_SEPT08 HSI[removed] HSI_MembersAlert_SEPT08:HSI_MembersAlert_SEPT08 HSI[removed]](https://www.pdfsearch.io/img/8b741b206ced34484c158f1deb1b3a56.jpg) | Add to Reading ListSource URL: www.rain-tree.comLanguage: English - Date: 2012-12-17 01:23:01
|
---|